Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Published:2021-02 Issue:2 Volume:21 Page:226-240
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Bassetti Matteo,Echols Roger,Matsunaga Yuko,Ariyasu Mari,Doi Yohei,Ferrer Ricard,Lodise Thomas P,Naas Thierry,Niki Yoshihito,Paterson David L,Portsmouth Simon,Torre-Cisneros Julian,Toyoizumi Kiichiro,Wunderink Richard G,Nagata Tsutae D

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference32 articles.

1. White paper: developing antimicrobial drugs for resistant pathogens, narrow-spectrum indications, and unmet needs;Boucher;J Infect Dis,2017

2. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics,2017

3. European prospective cohort study on enterobacteriaceae showing resistance to carbapenems (EURECA): a protocol of a European multicentre observational study;Gutiérrez-Gutiérrez;BMJ Open,2017

4. Treatment options for carbapenem-resistant Gram-negative bacterial infections;Doi;Clin Infect Dis,2019

5. New treatment options for multiresistant Gram negatives;Paterson;Curr Opin Infect Dis,2020

Cited by 500 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of adult patients with multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia treated with monotherapy versus combination therapy in a tertiary hospital;Diagnostic Microbiology and Infectious Disease;2024-11

2. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials;Journal of Infection and Chemotherapy;2024-11

3. Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis;BMC Infectious Diseases;2024-09-13

4. Transmission Dynamics and Novel Treatments of High Risk Carbapenem-Resistant Klebsiella pneumoniae: The Lens of One Health;Pharmaceuticals;2024-09-12

5. Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex;Expert Review of Anti-infective Therapy;2024-09-08